Vaccines
Where
extraordinary minds
help protect half a billion people
Vx - Medical Head, New Products and Innovation - Beijing/Shanghai
Shanghai, China
Who we are
Every day, 2.5 million Sanofi vaccine doses reach patients worldwide - powered by bold ideas, cutting-edge science, and passionate people like you. Across every stage — from discovery to delivery — Sanofians are shaping the future of vaccines. In global R&D hubs, exceptional offices, and state-of-the-art manufacturing sites, we’re reimagining what’s possible. But science alone isn’t enough — it’s the extraordinary minds behind it that truly make the difference.
JOB PURPOSE:
The Medical Head for Greater China will lead the medical strategy development and execution for the pre-launch phase of new vaccines/innovative prophylactic products. This role focuses on building a strong scientific foundation, planning/driving data generation, driving stakeholder engagement, and supporting cross-functional teams to ensure a successful launch in Greater China. The candidate will bring a Pharma 2.0 mindset & experiences, combining innovation, agility, and collaboration to thrive in a rapidly evolving healthcare landscape.
KEY ACCOUNTABILITIES:
1. Medical Strategy
• Develop and execute the medical strategy for the vaccine’s pre-launch activities in Greater China, particularly data generation.
• Align local plans with global strategies while addressing local market needs.
2. Medical Evidence Generation
• Lead the development and execution of comprehensive medical evidence generation strategies for new/innovative products in Greater China, collaborating with global teams and local stakeholders
• Design and implement robust medical/real world studies that address local healthcare needs and the company’s strategic goals
• Establish strategic partnerships with key opinion leaders (KOLs), academic institutions, healthcare organisations such as hospitals, and public health authorities to enhance scientific evidence and drive value recognition of immunization
3. Stakeholder Engagement
• Build and maintain relationships with KOLs, medical societies, and public health stakeholders
• Organize advisory boards and scientific discussions to generate insights and advocacy
4. Clinical and Scientific Support
• Provide medical expertise for regulatory and other submissions
• Drive/support disease burden/real-world evidence generation and Phase IV studies, if applicable
5. Medical Training and Communication
• Deliver training and scientific materials to internal teams and external stakeholders
• Ensure close collaboration & alignment with cross functions in Greater China and with global medical function/other counterparts
JOB-HOLDER ENTRY REQUIREMENTS:
Needed experience, qualifications and competencies
1. Education
MD, PhD or equivalent advanced degree in a relevant field (e.g., infectious diseases, immunology
2. Experience
8+ years in medical affairs or related roles in the pharmaceutical/vaccine industry
Proven track record in pre-launch strategy and stakeholder engagement in Greater China
Strong expertise and experiences in medical evidence data generation
3. Functional/technical competencies
Fluent in English
Good knowledge of study execution, benefit risk management and regulatory affairs
Excellent medical science knowledge of in general including main competitors
Good knowledge of vaccinology
Highly innovative with the ability to drive a complex and changing environment and effectively manage and resolve issues within the TA/field
In-depth knowledge of study methodology, study design, data review and analysis
Excellent knowledge of study publication processes and publications
Strong understanding of the pharmaceutical business
4. Behavioral competencies
Excellent organizational skills, ability to work in teams
Strong in communication, negotiating & presentation skills
Ability to interact successfully with all levels of stakeholders
5. Leadership competencies
Ability to build effective partnerships between internal stakeholders
Find out more about this location
Why work with us
- We’re problem-solvers and pioneers. United by the belief that everyone deserves a healthier future. We create best-in-class vaccines that prevent disease and protect lives.
- Innovation drives us. From AI and mRNA to next-gen science, we push the boundaries to deliver first- and best-in-class vaccines for infectious diseases worldwide.
- Growth happens here. With bold investments in R&D and world-class facilities, Sanofians across the entire vaccine lifecycle are shaping the future of global health.
- We do what’s right. Sustainability and DE&I drive our positive global impact—because the diverse communities Sanofians represent are the patients we serve.
What does it take to protect the world from disease?
For over a century, we’ve been pioneering breakthroughs that help protect millions from diseases like polio, influenza, RSV, and more. And we’re not stopping there.
Powered by groundbreaking technologies - mRNA platforms, recombinant proteins, and AI-driven insights - we’re pushing the boundaries of science.
"I’m immensely proud of the pace of our innovation – the urgency by which our teams are working to transform the practice of medicine."
Thomas Triomphe
Executive Vice President, Vaccines
Discover more
Sanofi’s mRNA Center of Excellence
Step into the future of healthcare with Sanofi’s mRNA Center of Excellence. Discover how a global team is transforming medicine with cutting-edge mRNA technology – and explore the skills, inspirations, and breakthroughs driving this revolution. Ready to shape the future?
About Sanofi Vaccines
Explore our commitment to protecting global health through the power of vaccines. We’re building healthier communities with innovative solutions that save millions of lives each year. Dive into the future of vaccines, discover the diseases we’re tackling, and learn why vaccination is critical at every stage of life.
Join our
talent community
What could we achieve together? Every Sanofian works on projects that truly make a difference to people’s lives.
Sign up today and discover our latest opportunities as soon as they’re available.